Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?

Does Ertapenem Alter the Susceptibility ofPseudomonas aeruginosato Carbapenems?

(2014) B. Beović et al.   JOURNAL OF CHEMOTHERAPY

Carbapenem stewardship – positive impact on hospital ecology

(2012) Ana Lucia Lei Munhoz Lima et al.   Brazilian Journal of Infectious Diseases

Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia

(2012) D. A. J. McDougall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study

(2011) Paul P. Cook et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study

(2011) Yehuda Carmeli et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary

(2011) C. J. GRABER et al.   EPIDEMIOLOGY AND INFECTION

Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates

(2011) Rodrigo Pires dos Santos et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence

(2011) David P. Nicolau et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem

(2011) K. J. Eagye et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Stewardship Lessons: Do Pseudomonas-Sparing Agents, Such as Ertapenem, Effectively Improve Bacterial Resistance?

(2010) R. P. dos Santos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008

(2010) S. Hawser et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa

(2009) E. J. C. Goldstein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Impact of Ertapenem Use on the Susceptibility of Pseudomonas aeruginosa to Imipenem A Hospital Case Study

(2009) Ana Lucia L. Lima et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Ertapenem: No effect on aerobic gram-negative susceptibilities to imipenem

(2008) Debra A. Goff et al.   JOURNAL OF INFECTION